The field of biopharma has always been at the forefront of global scientific, medical, and commercial innovation. From gene editing and personalized medicine to cell therapy and novel treatment options, biopharma is evolving at an unprecedented pace, offering new therapeutic choices to patients worldwide.
The 4th World Congress of Biopharm Industry Development (BID-2025) will take place in Fengxian, Shanghai, from September 24-26, 2025, with the theme "Bridging Global High-end Talents, Empowering Industrial Innovation". This conference aims to be one of the most significant events in the global biopharma field in 2025, providing an exceptional platform for exchange, collaboration, and the shaping of the future direction of the biopharmaceutical industry.
The conference will feature a variety of activities, including: Keynote speeches by leading experts, scientific forums and panel discussions, Exhibitions and poster presentations, Networking opportunities, Site visits. In addition, seven specialized forums will focus on key areas of biopharma, including: Frontier Research in Drug Discovery, Cutting-Edge Drug Discovery Technologies, Drug Discovery Chemistry Innovation, Novel Drug Delivery Technologies and Systems, Gene and Cell Therapy Innovation & Development, Next-Generation Protein and Peptide Drugs, Pharmaceutical Process Development & Manufacturing.
As always, this conference is dedicated to fostering mutual support and intellectual exchange among scientists and industry leaders from around the globe. We sincerely invite global talents to join us in Shanghai, where they can contribute to revitalizing international cooperation and advancing the Chinese biomedicine industry to the forefront of global innovation.
Guiding Organization Shanghai Fengxian People's Government Hosting Organizations Shanghai Fengxian Science and Technology Committee Shanghai Fengxian Talent Work Bureau Shanghai Fengxian Investment Promotion Office Shanghai Fengxian Human Resources and Social Security Bureau |
Supporting Organization Chinese Society of Biotechnology Operating Organizations BIT Convention Inc. Shenzhen Center for International Exchange of Personnel National Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, China |
Biopharm Industry Development Sector | |||||
![]()
Balazs Sarkadi |
![]()
Olivier Gascuel |
![]()
Martin Rocken |
![]()
Lee Jia |
![]()
Sergey Suchkov |
![]() Yongxiang Zhao |
![]()
Alexander Tuzikov |
![]()
Zhongchao Han |
![]()
Shuxiang Guo |
![]()
Qiao Li |
![]()
Xiaoliang Wang |
![]()
Gerhard Jahn |
![]()
Guoxiong Xu |
![]()
Wu Yuming |
![]()
Xuemei Zhang |
![]()
Yi Zhang |
![]()
Jinqiang Wang |
![]()
Xifeng Wu |
![]()
Muxiang Zhou |
![]()
Jacek Kubiak |
![]()
Xiaoyang Qi |
![]()
Farhid Hemmatzadeh |
![]()
Lilya Maya Ziad |
![]()
Chunlin Xin |
![]()
Holger Krenz |
![]()
Christopher Missling |
![]()
Lixia Wang |
![]()
Meiling Li |
![]()
Chaitanya Suri |
![]()
Whitney Liu |
![]()
Qun (Max) Dang |
![]()
George Zhang |
![]()
Jieyi Wang |
![]()
Jukka Kervinen |
![]()
Helena Shifrin |
![]()
Bo Meng |
![]()
Regis Launay |
![]()
Urban Fagerholm |
![]()
Wilfried Dathe |
![]()
Umar Hayat |
![]()
Markus Roucka |
![]()
Wei Qu |
![]()
Li Xinfang |
![]()
Yongzeng Wang |
![]()
Jian Ni |
![]()
David R. Tabatadze |
![]()
Nick Zhang |
![]() Carrie Duan |
![]()
Yunchun Shen |
![]()
Hari Sharma |
![]()
Ana Cristina Faria Ribeiro |
![]()
Hwa-Chain Robert Wang |
![]()
Adele Maria Muscolo |
![]()
Etsuo Yonemochi |
![]()
Xiangyang Zhu |
![]()
Limei Lin |
![]()
Yulin Li |
![]()
Joerg Grosse-Onnebrink |
![]()
Jaejin Cho |
![]()
Ming-Chung Jiang |
![]()
Miguel A. Esteso |
![]()
Antonio Iannetti |
![]()
Xiangshi Tan |
![]()
Xianpeng Ge |
![]()
Xingyuan Ma |
![]()
Jun Xu |
![]()
Mengxi Jiang |
![]()
Xiangyang Ye |
![]()
Chunmin Liang |
![]()
Chuanshu Huang |
![]()
Shengyong Xu |
![]()
Chunjiu Zhong |
![]()
Lijuan Chen |
![]()
Hui Qian |
![]()
Siyong Huang |
![]()
Kecheng Zhou |
![]()
Ramendra Pati Pandey |
![]()
Zhankui Sun |
![]()
Satomi Onoue |
![]()
Xiaohong Liang |
![]()
Min Yue |
![]()
Zenan Wang |
![]()
Xiangdong Xue |
![]()
Magdalini Matziari |
![]()
Zhongwei Li |
![]()
Rui Qing |
![]()
Qiuqin He |
![]()
Manash P Baruah |
![]()
Faez Iqbal Khan |
![]()
Libo Zhou |
![]()
Rui M. M. Brito |
![]()
Jun Fang |
![]()
Haiping Zhang |
![]()
Leona Raskova Kafkova |
![]()
Cunzhong Yuan |
![]() Shuang Tang |
Synthetic Biology Sector | |||||
![]()
Qiang Wu |
![]()
Renxiang Tan |
![]()
Michael P. Timko |
![]()
Peter Sachsenmeier |
![]()
Dan Wang |
![]()
Cheng Li |
![]()
Walter Holweger |
![]()
Tingting Deng |
![]()
Ji Cao |
![]()
Zhang Xin |
![]()
Chun Loong Ho |
![]()
Yaojun Tong |
Senolytics & Longevity Sector | |||||
![]()
Yong Shen |
![]()
Jiankang Liu |
![]()
John Van Limburg Stirum |
![]()
Mario Barbagallo |
![]()
Chuanhua Yu |
![]()
Gaiqing Wang |
![]()
Robert Zheng |
![]()
Guanchang Cheng |
![]()
Constantin Munteanu |
![]()
Henri Jean Aubin |
![]()
Weidong Le |
![]()
Chunhong Ma |
Beauty Products Industry Sector | |||||
![]()
Evgeniya Ranneva |
![]()
Peter Verheyen |
![]()
Dariush Honardoust |
![]()
Choi Kyu Jin |
![]()
Andrea Bonanno |
![]() Bin Chen |
Enzyme Innovation Sector | |||||
![]()
Feng He |
![]()
GHulam Abbas Ashraf |
![]()
Shou-Kuan Tsai |
![]()
Sumin Bian |
![]()
Muhammad Anwar |
![]() Weizhuo Xu |
Stem Cell Technology
Molecular and Cellular Biology Technologies and Products
Immunotherapy
Next-Generation Sequencing Technology, Gene and Genome Editing
Synthetic Biology
Bioanalysis and Laboratory Automation
Bio-IT / Health IT and Digital Healthcare Products
Senolytics & Longevity
Tissue Engineering
Cell Technology and Therapy
Gene Therapy
Antibody and Vaccine Technology
Medical Imaging Technology
Beauty Products
Beauty Tech Innovations
New Medical Technology
Medical Devices
Laboratory Equipment
Keynote Forum
![]() |
Exhibition
![]() |
Project and Investment Matchmaking
![]() |
Welcome Banquet
![]() |
Field Trip to Industrial Parks
![]() |
Interview
![]() |